Literature DB >> 27170145

The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Christiana T Vogkou1,2, Nikolaos I Vlachogiannis1,2, Leonidas Palaiodimos3,4, Antonis A Kousoulis1,5.   

Abstract

Infective endocarditis (IE) incidence remains high with considerable fatality rates; guidelines for prophylaxis against IE are currently under review in some settings which highlights the importance of maintaining up-to-date epidemiological estimates about the most common microbial causes. The objective of this systematic review, following PRISMA guidelines, was to identify the most common microbial causes of IE in recent years. Medline was searched from January 1, 2003 to March 31, 2013 for all articles containing the term "infective endocarditis". All relevant studies reporting diagnostic results were included. Special patient subpopulations were assessed separately. A total of 105 studies were included, from 36 countries, with available data on a total of 33,214 cases. Staphylococcus aureus was found to be the most common microorganism, being the most frequent in 54.3 % of studies (N = 57) (and in 55.4 % of studies using Duke's criteria for diagnosis [N = 51]). Viridans group streptococci (VGS), coagulase-negative staphylococci (CoNS), Enterococcus spp and Streptococcus bovis were among the most common causes. S. aureus was the most common pathogen in almost all population subgroups; however, this was not the case in patients with implantable devices, prosthetic valves, or immunocompromised non-HIV, as well as in the sub-group from Asia, emphasizing that a global one-size-fits-all approach to the management of suspected IE is not appropriate. This review provides an evidence-based map of the most common causative agents of IE, highlighting S. aureus as the leading cause in the 21st century. The changing epidemiology of IE in some patient sub-groups in the last decade and the very high number of microbiologically undiagnosed cases (26.6 %) suggest the need to revisit IE prophylaxis and diagnostic strategies.

Entities:  

Mesh:

Year:  2016        PMID: 27170145     DOI: 10.1007/s10096-016-2660-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  125 in total

1.  Incidence and complication rate of infective endocarditis in the Dutch region of Walcheren: a 3-year retrospective study.

Authors:  Jeroen Walpot; Willem Blok; Jan van Zwienen; Cees Klazen; Bram Amsel
Journal:  Acta Cardiol       Date:  2006-04       Impact factor: 1.718

2.  Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota.

Authors:  Daniel D Correa de Sa; Imad M Tleyjeh; Nandan S Anavekar; Jason C Schultz; Justin M Thomas; Brian D Lahr; Alok Bachuwar; Michal Pazdernik; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

3.  Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis.

Authors:  Elzbieta Abramczuk; Tomasz Hryniewiecki; Janina Stepińska
Journal:  Kardiol Pol       Date:  2006-07       Impact factor: 3.108

4.  Audit of antibiotic therapy used in 66 cases of endocarditis.

Authors:  E Demonchy; P Dellamonica; P M Roger; E Bernard; E Cua; C Pulcini
Journal:  Med Mal Infect       Date:  2011-09-15       Impact factor: 2.152

Review 5.  Infective endocarditis: the European viewpoint.

Authors:  Pilar Tornos; Teresa Gonzalez-Alujas; Frank Thuny; Gilbert Habib
Journal:  Curr Probl Cardiol       Date:  2011-05       Impact factor: 5.200

6.  Endocarditis at a tertiary hospital: reduced acute mortality but poor long term prognosis.

Authors:  Cao Thach Tran; Keld Kjeldsen
Journal:  Scand J Infect Dis       Date:  2006

7.  Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.

Authors:  S Leone; V Ravasio; E Durante-Mangoni; M Crapis; G Carosi; P G Scotton; N Barzaghi; M Falcone; P Chinello; M B Pasticci; P Grossi; R Utili; P Viale; M Rizzi; F Suter
Journal:  Infection       Date:  2012-06-19       Impact factor: 3.553

8.  Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database.

Authors:  T Lalani; Z A Kanafani; V H Chu; L Moore; G R Corey; P Pappas; C W Woods; C H Cabell; B Hoen; C Selton-Suty; T Doco-Lecompte; C Chirouze; D Raoult; J M Miro; C A Mestres; L Olaison; S Eykyn; E Abrutyn; V G Fowler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

9.  Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984-2006) in slovakia.

Authors:  V Hricak; B Liska; J Kovackova; J Mikusova; V Fischer; J Kovacik; M Karvaj; R Jurco; A Ondrusova; E Kalavsky; P Marks; P Beno; V Krcmery
Journal:  J Chemother       Date:  2007-04       Impact factor: 1.714

10.  Outcome and prognostic factors on 57 cases of infective endocarditis in a single centre.

Authors:  Chi Wing Wong; Graeme Porter; Jonathan Tisch; Calum Young
Journal:  N Z Med J       Date:  2009-10-09
View more
  31 in total

Review 1.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

2.  Infective endocarditis and outcomes of valve surgery: the bug, the valve, the host and the unknown.

Authors:  Sudarshan Balla; Mohamad Alkhouli
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 3.  Infective endocarditis in South Africa.

Authors:  Alfonso Jan Pecoraro; Anton Frans Doubell
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

4.  A comparison of different antibiotic regimens for the treatment of infective endocarditis.

Authors:  Arturo J Martí-Carvajal; Mark Dayer; Lucieni O Conterno; Alejandro G Gonzalez Garay; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2020-05-14

5.  Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models.

Authors:  Anna Gomes; Lars van der Wijk; Johannes H Proost; Bhanu Sinha; Daan J Touw
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

6.  Epidemiologic and clinical characteristics of infective endocarditis: a single-center retrospective study in the Bronx, New York.

Authors:  Wasla Liaqat; Leonidas Palaiodimos; Weijia Li; Dimitrios Karamanis; Arooj Tahir; Andreas Tzoumas; Sanjana Nagraj; Nidhish Tiwari; Michael Grushko; Damianos Kokkinidis; Eleonora Gashi; Jason Leider; Christina Coyle; Robert T Faillace
Journal:  Infection       Date:  2022-05-25       Impact factor: 7.455

Review 7.  Workup and Management of Native and Prosthetic Valve Endocarditis.

Authors:  Aref A Bin Abdulhak; Abdul H Qazi; Imad M Tleyjeh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-07

Review 8.  Infective endocarditis: trends, surgical outcomes, and controversies.

Authors:  Mahbub Jamil; Ibrahim Sultan; Thomas G Gleason; Forozan Navid; Michael A Fallert; Matthew S Suffoletto; Arman Kilic
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

9.  High-throughput Screening of Small Molecule Inhibitors of the Streptococcus Quorum-sensing Signal Pathway.

Authors:  Seiji Ishii; Kenji Fukui; Satoshi Yokoshima; Kazuo Kumagai; Youko Beniyama; Tetsuya Kodama; Tohru Fukuyama; Takayoshi Okabe; Tetsuo Nagano; Hirotatsu Kojima; Takato Yano
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

10.  Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis.

Authors:  Jonathan Save; Yok-Ai Que; José M Entenza; Camille Kolenda; Frédéric Laurent; Grégory Resch
Journal:  J Am Heart Assoc       Date:  2022-01-19       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.